Brief: Rallybio Reports Second Quarter 2023 Financial Results
Aug 8 (Reuters) - Rallybio Corp RLYB.O :
* RALLYBIO REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATES
* RALLYBIO CORP - $137.8 MILLION CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES AS OF JUNE 30, 2023; PROVIDES RUNWAY INTO
1Q 2025
Source text for Eikon: ID:nBwhPmP7a
Further company coverage: RLYB.O
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx